PROTAC AR Degrader-8 - HY-170329
Nur noch %1 verfügbar
Catalog #
HY-170329
Ab
465,00 €
PROTAC AR Degrader-8 (Compound NP18) is the PROTAC degrader for androgen receptor (AR), that degrades AR-FL with DC50 of 0.018 μM and 0.14 μM in 22Rv1 cell and LNCaP cell, degrades AR-V7 with DC50 of 0.026 μM in 22Rv1 cell. PROTAC AR Degrader-8 inhibits the proliferation of cancer cell 22Rv1 and LNCaP with IC50 of 0.038 μM and 1.11 μM. PROTAC AR Degrader-8 arrests cell cycle at G2/M phase, induces apoptosis in 22Rv1 cell. PROTAC AR Degrader-8 exhibits anticancer efficacy in mouse and zebrafish model[1]. (Pink: ligand for target protein AR ligand-33 (HY-170330); Black: linker (HY-W007731); Blue: ligand for E3 ligase Cereblon (HY-14658))
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-170329/PROTAC-AR-Degrader-8-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-programmed cell death |
| CAS | 3044108-04-2 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 703.78 |
| Solubility | DMSO : ≥ 100 mg/mL |
| Clinical Information | No Development Reported |
| Target | Androgen Receptor;Apoptosis;PROTACs |
| Application: | Cancer-programmed cell death |
|---|